Relmada Therapeutics (RLMD) Return on Capital Employed (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Relmada Therapeutics 595.35 Mn 595.35 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8,335.00
Dec 31, 2025 32,856.00
Sep 30, 2025 -8,556.00
Jun 30, 2025 -11,506.00
Mar 31, 2025 -4,380.00
Dec 31, 2024 -4,149.00
Sep 30, 2024 -3,180.00
Jun 30, 2024 -861.00
Mar 31, 2024 -1,157.00
Dec 31, 2023 -592.00
Sep 30, 2023 361.00
Jun 30, 2023 120.00
Mar 31, 2023 -1,030.00
Dec 31, 2022 -1,560.00
Sep 30, 2022 -717.00
Jun 30, 2022 -1,188.00
Mar 31, 2022 2,078.00
Dec 31, 2021 4,764.00
Sep 30, 2021 -4,300.00
Jun 30, 2021 -1,859.00
Mar 31, 2021 -1,886.00
Dec 31, 2020 -1,763.00
Sep 30, 2020 -974.00
Jun 30, 2020 -542.00
Mar 31, 2020 778.00
Jun 30, 2019 102,190.00
Mar 31, 2019 40,068.00
Dec 31, 2018 -191,115.00
Mar 31, 2018 -410,721.00
Dec 31, 2017 44,349.00
Sep 30, 2017 -53,229.00
Jun 30, 2017 -12,426.00
Mar 31, 2017 -5,609.00
Dec 31, 2016 3,294.00
Sep 30, 2016 43.00
Jun 30, 2016 -4,962.00
Mar 31, 2016 -228.00
Dec 31, 2015 -2,654.00
Sep 30, 2015 4,818.00
Jun 30, 2015 34,391.00
Mar 31, 2015 47,420.00
Dec 31, 2014 -106,057.00
Nov 30, 2013 387.00
Aug 31, 2013 -6,906.00